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Abstract
Cancer cells are mainly dependent on glycolysis for their growth and survival. Dietary 
carbohydrates play a critical role in the growth and proliferation of cancer and a low-carbohydrate 
diet may help slow down the growth of tumours. However, the exact mechanisms behind this effect 
are unclear. This review study aimed to investigate the effect of fat mass and obesity-associated 
(FTO) gene in the association between dietary carbohydrates and cancer. This study was carried 
out using keywords such as polymorphism and/or cancer and/or dietary carbohydrate and/or FTO 
gene. PubMed and Science Direct databases were used to collect all related articles published from 
1990 to 2018.
Recent studies showed that the level of FTO gene expression in cancer cells is dramatically 
increased and may play a role in the growth of these cells through the regulation of the cellular 
metabolic pathways, including the phosphoinositide 3-kinases/protein kinaseB (PI3K/AKT) 
signaling pathway. Dietary carbohydrate may influence the FTO gene expression by eliminating the 
inhibitory effect of adenosine monophosphate-activated protein kinase (AMPK) on the FTO gene 
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expression. This review summarised what has been recently discovered about the effects of dietary 
carbohydrate on cancer cells and tried to determine the mediating role of the FTO gene in these 
effects.
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mass and obesity-associated (FTO) gene (18). 
The association between the FTO gene and 
obesity has been confirmed through the study 
of the FTO gene polymorphisms. People who 
have the risk allele in the polymorphisms of 
the FTO gene (e.g. rs9939609 & rs9930506) 
have a greater risk of developing obesity (19). 
The amount of FTO gene expression in various 
tissues is also linked to body fat percentage and 
obesity (20). More recently, studies have shown 
that some of the effects of the FTO gene may be 
due to the impact of the intron regions of this 
gene on the expression of other genes, including 
the iroquois homeobox gene 3 (IRX3 gene) (21). 
The interactions between diet and the FTO gene 
have been recently reported in some studies (22). 
Considering the role of carbohydrates in cancer 
cell metabolism, this study aimed to investigate 
the mediating role of the FTO gene in the effect 
of dietary carbohydrates on cancer cells. First, we 
reviewed the role of several diets with different 
amounts of macronutrients administered to 
cancer patients. Then, we studied the role of 
the macronutrients in FTO gene expression. 
The probable molecular mechanisms of the 
association between the FTO gene and cancer 
development were also reviewed.
Methodology
PubMed, PsycInfo and the Cochrane 
databases were searched to identify articles 
published in relevant fields. Appropriate 
keywords including carbohydrate, diet, FTO 
expression, FTO genotype, cancer, cell and 
metabolism (alone and together) were used 
to collect the papers. All articles published 
in English from June 1990 to July 2018 were 
studied. Of the total 180 articles, 109 articles 
were excluded because they failed to address 
the role of the FTO gene in breast cancer and/
or obesity and 63 articles for lack of sufficient 
information on the mechanism of the effects 
of FTO gene on the breast cancer and obesity. 
Finally, eight articles were included. Of these 
studies, five studies were on the relationship 
between dietary carbohydrate and cancer, and 
five were related to the molecular mechanisms of 
dietary carbohydrate on FTO gene.
Introduction
Recent studies suggested that healthy 
diet can play a major role in the prevention of 
cell malignancy, apoptosis of cancer cells and 
reduced tumour size (1–6). For example, the role 
of many vitamins and phytochemicals (such as 
curcumin) in cellular division and apoptosis has 
been frequently reported (7–9). More recently, 
the role of macronutrients such as carbohydrate 
in controlling the growth of cancer cells has 
attracted the attention of scientists (10). Cancer 
cells are dependent on their access to glucose 
for growth and reproduction; controlling blood 
glucose at an optimal level in cancer patients 
may be a practical way to avoid increasing 
the size of a tumour (11). One of the most 
recommended diets is the ketogenic diet that 
may be effective in reducing cancer cell growth 
by reducing the level of glucose availability (12).
Until recently not a lot has been found 
about the existing mechanisms by which dietary 
components affect the formation of cancer cells. 
The results of most studies suggest that some 
part of this effect may be due to the effects of 
dietary intake on the expression of some of 
the genes involved in the cell metabolism and 
division. The relation between gene variations 
and risk of cancer is well documented (13, 14). 
Cancer is a genetic disease caused by changes in 
the genes which have a role in the control of the 
growth, division and function of our cells (14). 
When tumour suppressor genes such as breast 
cancer genes 1 and 2 (BRCA1, BRCA2), and 
P53 carry a mutation, the cells can grow out of 
control and may lead to tumour formation (15). 
Recent studies have focused on the genes that 
are influenced by the environmental factors like 
dietary intake. It is assumed that the amount of 
nutrients available to the cell may modify the 
level of expression of some genes associated with 
cell growth and proliferation (16, 17). In other 
words, it is possible that dietary components 
play a major role in the risk of developing cancer 
through their effects on the expression of certain 
genes involved in the growth and proliferation 
of cancer cells (17). One of the genes that has 
recently been featured in this context is the fat 
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of the cancer growth pathway and it seems that 
the reduction of insulin levels through diet or 
medication (e.g. metformin) was beneficial in 
cancer patients (26).
Sieri et al. conducted a cohort study and 
examined whether the glycemic load (GL) and 
the glycemic index (GI) are associated with 
the risk of breast cancer in women (27). A 
total of 289 patients with breast cancer were 
followed after 11.5 years. The results showed 
that the relative risk of the development of 
cancer with high GI and high GL were 1.57 and 
2.53, respectively (P < 0.05). The risk of breast 
cancer was associated with the consumption 
of carbohydrates with higher GIs (P for trend 
< 0.001).
The association between hyperglycemia 
and cancer risk was examined in 33,293 women 
and 31,304 men in northern Sweden (28). The 
results showed that the overall risk of cancer 
in women with the top quartile of fasting blood 
sugar (FBS) and blood sugar (BS) compared to 
bottom quartile was 1.75 versus 1.63. The risks of 
pancreatic, endometrium, urinary tract pipe and 
malignant melanoma cancers were associated 
with high FBS level, with the relative risk of 2.49, 
1.86, 1.69, and 2.19, respectively.
Tan-Shalaby et al. examined the impact of 
the modified Atkins diet on cancer development. 
A total of 17 patients with advanced cancer, who 
had not undergone chemotherapy, were enrolled 
for the study (29). They received 20 g–40 g 
of carbohydrates daily for 16 weeks and were 
assessed every 4 weeks. The results showed that 
the modified Atkins diet is a safe and practical 
approach to prevent cancer progression and it 
can promote the quality of life. The survival time 
was also improved in some patients with lung 
cancer and melanoma. 
Moreover, the effect of ketogenic diet as a 
well-known low-carbohydrate diet on tumour 
growth was investigated and approved in several 
studies (30–39). Reducing the amount of dietary 
carbohydrates is reported to suppress—or at 
least delay—the incidence of cancer and slow 
down the proliferation of cancer cells (30–34). 
Carbohydrates can have direct and indirect 
effects on the proliferation of cancer cells (40). 
A recent study identified that an increase in 
ketone bodies after a decrease in insulin and 
blood glucose had a negative effect on the 
proliferation of malignant cells in vitro during a 
calorie-restricted diet (41). It has recently been 
reported that the dependency of cancer cells on 
glycolysis (Warburg effect) may have a key role 
Dietary Carbohydrate and Cancer
Unlike normal cells, most malignant cells 
are dependent on the availability of sugar in 
the blood constantly for energy supply and to 
meet demands for their metabolism. These 
cells are unable to metabolise fatty acids and 
ketone bodies due to mitochondrial dysfunction. 
Previous studies reported the benefits of a low- 
carbohydrate diets on human body weight and 
general health (23). Ho et al. compared the 
effects of a low-carbohydrate diet compared 
to a western diet on tumour growth in mice 
(24). They first designed a low carbohydrate 
diet containing 8% carbohydrate (% of total 
calories), 23% fat and 69% protein versus a 
western diet (55% carbohydrate, 23% protein, 
22% fat). The results showed that the growth of 
the cancer cells in low-carbohydrate and high-
protein group was slower than their growth in a 
high-carbohydrate western diet. There were no 
differences between the weights of the cancer-
bearing mice in the two groups. In addition, 
mice with a low-carbohydrate diet had lower 
levels of blood sugar, insulin and lactate. Only 
one rat on western diets could have a normal 
lifespan with cancer-related death, while more 
than 50% of the mice with a low-carbohydrate 
diet had a normal lifespan. It is also suggested 
that a low-carbohydrate diet possibly slows 
down the growth of cancer cells by reinforcing 
the inhibitory effects on the mechanistic target 
of rapamycin (mTOR) pathway. Taken together, 
the findings of this study revealed the ability 
of a low-carbohydrate diet to slow down the 
development of cancer without any impacts on 
weight.
Moulton et al. evaluated the effects of two 
different ratios of carbohydrate and protein 
in the early development of breast tissue 
carcinogenesis in an animal study (25). After 
tumour induction, the mice were exposed to 
either a low-protein and high-carbohydrate 
[(LPHC); 15% and 60% of energy, respectively] 
diet or a high-protein and moderate-
carbohydrate [(HPMC); 35% and 40% of 
energy, respectively] diet for 10 weeks. The rate 
of the palpable tumours in the HPMC group 
compared to the LPHC group was lower and the 
level of insulin serum in the LPHC group was 
significantly higher than in the HPMC group. The 
researchers concluded that a low-carbohydrate 
diet can help to slow down the growth of breast 
tumours. The insulin-like growth factor 1 
(IGF-1) system was reported as a key regulator 
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polymorphisms play a role in the association 
between carbohydrate intake and FTO gene 
expression (52, 53). Some recent studies 
showed the impact of carbohydrate intake 
on the association between FTO and BMI. A 
cross-sectional study on 4,839 Swedish people 
showed that the relation between FTO gene 
polymorphisms and obesity can be seen only in 
people who have a high rate of fat and low rate 
of carbohydrate intake (52). However, the results 
in this area were contradictory. For example, in 
a study by Qi et al. on 16,094 patients between 
1 and 18 years, carbohydrate intake had no 
effect on the relationship between FTO and BMI 
(Table 1) (53).
The possible mechanism behind the effect 
of the FTO gene on cancer risk has been studied 
recently. The FTO gene may act as a mediator for 
the phosphorylation of serine in location 473 of 
the AKT protein and its activation has a key role 
in the proliferation and differentiation of cells 
(54). It was assumed that an increase in the FTO 
gene expression can increase glycolysis in the 
cancer cells by effect on the PI3K/AKT signaling 
pathway (55). It was also reported that the PI3K/
AKT pathway is a mediator of the association 
between estrogen and the level of FTO gene 
expression and subsequent cell survival (56). It 
seems that the association between the FTO gene 
and cancer cells is more tangible in hormone-
dependent cancers (Figure 1). 
Conclusion
Cancer cells are dependent on glycolysis 
for their growth and proliferation. Dietary 
carbohydrate is a significant factor and the 
association between blood glucose levels and 
cancer is well documented. But the exact 
mechanisms of this relationship remain 
unclear. Recent studies showed that dietary 
macronutrients may have an impact on cancer 
by altering the expression level of the genes 
associated with the metabolism of cancer 
cells (such as FTO). If we could improve the 
expression levels of the genes involved in 
growth, metabolism, and the function of cancer 
cells through changing our diet, we can hope to 
find a nutritionally applicable solution for the 
treatment and control of cancer in the future. 
Further research on the exact mechanism of 
the influence of FTO gene on the growth and 
proliferation of cancer cells may clarify the 
importance of this issue and the possibility of 
therapeutic use of dietary components in cancer. 
in the progression of cancer cells, but is not a 
cause of it (42). The studies on the mechanism 
of the effect of carbohydrates on the growth 
and proliferation of cancer cells reported that 
high levels of blood glucose and insulin will 
apply some of their effects through the steady 
activation of phosphoinositide 3-kinase/protein 
kinase B (PI3K/AKT) pathway that is involved in 
cell survival and eventually increase the risk of 
cancer (43, 44). However, the precise mechanism 
behind these effects of carbohydrate on this 
metabolic pathway is unclear.
FTO Has a Possible Mediatory 
Role in the Association between 
Carbohydrates and Breast Cancer
FTO gene is known for its role in obesity 
and diabetes (19). The association between the 
FTO gene expression and cancer risk was also 
recently identified (45–47). The FTO gene may 
exert its effect through different mechanisms. 
It was reported that the level of FTO gene 
expression is higher in cancer cells than in 
normal cells and the cells adjacent to cancer 
tissue (45, 46). Moreover, the polymorphisms 
in the FTO gene are associated with cancer and 
may exert their role through their influence on 
the expression of the effective genes in cancer 
(47). However, some studies showed that 
there is no association between the FTO gene 
polymorphisms and the risk of cancer (48, 49). 
Yang et al. reported that there is no evidence 
that the gene variants in FTO are associated 
with a risk of colorectal cancer (49). In another 
study, the FTO rs11075995 variant risk allele was 
reported to be associated with breast cancer risk, 
without adjustment for body mass index (BMI). 
However, the adjustment to BMI led to the 
disappearance of this association, indicating that 
there is no independent association between the 
FTO polymorphism and the risk of breast cancer 
(50). 
Recent studies on the relationship between 
the macronutrients intake and the level of FTO 
gene expression in the hypothalamus identified 
that dietary carbohydrates can affect the FTO 
gene expression level. However, the results 
in this area are contradictory and in some 
studies carbohydrate intake up-regulated the 
FTO gene expression, while in other studies 
it suppressed FTO gene expression (51). It is 
possible that this effects of dietary carbohydrates 
may depend on FTO genotype and FTO gene 
Malays J Med Sci. Mar–Apr 2019; 26(2): 8–17
www.mjms.usm.my12
Table 1. Summary of study descriptions
Reference Title Study design Examined components Main finding(s)
Dietary carbohydrate and cancer
Ho et al.  (24) A low-carbohydrate, high-protein 
diet slows tumour growth and 
prevents cancer initiation
Experimental A low-carbohydrate, 
high-protein diet vs 
a high-carbohydrate, 
low-protein diet
The ability of a low-
carbohydrate diet to slow 
down the development of 
cancer without any impact on 
weight
Moulton et al. 
(25)
A HPMC diet fed at discrete meals 
reduces early progression of 
N-methyl-N-nitrosourea-induced 
breast tumourigenesis in rats
Experimental A low-protein and 
high-carbohydrate 
diet vs HPMC diet
A low-carbohydrate diet can 
help to slow down the growth 
of breast tumours
Sieri et al. (27) Dietary GI, GL, and the risk 
of breast cancer in an Italian 
prospective cohort study
Cohort High GI and GL vs 
low GI and GL
GL and GI are associated 
with the risk of breast cancer 
in women
Stattin et al. (28) Prospective study of 
hyperglycemia and cancer risk
Cohort FBS and BS of the 
top quartile versus 
the bottom quartile
Hyperglycemia was 
associated with cancer risk
Tan-Shalaby  
et al. (29)
KD in advanced cancer: A pilot 
feasibility and safety trial in the 
veterans affairs cancer patient 
population
CT 20 g–40 g of 
carbohydrates daily 
for 16 weeks
The modified Atkins diet is 
safe and a practical approach 
to prevent cancer progression 
and helps to maintain the 
quality of life
Shukla et al. (30) Metabolic reprogramming 
induced by ketone bodies 
diminishes pancreatic cancer 
cachexia
Experimental Normal diet vs KD KD reduced tumour growth 
and inhibited body weight 
loss
Allen et al. (31) KD enhance oxidative stress and 
radio-chemo-therapy responses in 
lung cancer xenografts
Experimental Standard diet vs KD KD enhances radio-chemo-
therapy responses in lung 
cancer xenografts by a 
mechanism that may involve 
increased oxidative stress
Kim et al. (32) Carbohydrate restriction and 
lactate transporter inhibition in a 
mouse xenograft model of human 
PCa
Experimental WD vs KD Differences in tumour 
volumes were observed only 
in comparisons between mice 
fed a KD and mice fed a WD
Otto et al. (33) Growth of human gastric cancer 
cells in nude mice is delayed by a 
KD supplemented with omega-3 
fatty acids and MCT
Experimental Standard diet vs KD An unrestricted KD enriched 
with omega-3 fatty acids and 
MCT delayed tumour growth 
in a mouse xenograft model
Morscher  
et al. (34)
Inhibition of neuroblastoma 
tumour growth by KD and/or 
calorie restriction in a CD1-Nu 
mouse model
Experimental Standard diet vs KD KD reduced neuroblastoma 
tumour growth
Poff et al. (35) The KD and hyperbaric oxygen 
therapy prolong survival in mice 
with systemic metastatic cancer
Experimental Standard diet vs KD KD produced anti-cancer 
effects in metastatic cancer
Caso et al. (36) The effect of carbohydrate 
restriction on PCa tumour growth 
in a castrate mouse xenograft 
model
Experimental WD vs KD Carbohydrate restriction 
provided a benefit to 
slowing PCa tumour growth 
compared to a KD in mice
Abdelwahab  
et al. (37)
The KD is an effective adjuvant to 
radiation therapy for the treatment 
of malignant glioma
Experimental Standard diet vs KD KD significantly enhanced 
the anti-tumour effect of 
radiation
(continued on next page)
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Reference Title Study design Examined components Main finding(s)
Caso et al. (36) The effects of varying dietary 
carbohydrate and fat content 
on survival in a murine LNCaP 





improved the survival rate in 
PCa in humans
Hao et al. (39) Growth of human colon cancer 
cells in nude mice is delayed by 
KD with or without omega-3 fatty 
acids and MCT
Experimental Standard diet vs KD An unrestricted KD delayed 
tumour growth in a mouse 
xenograft model
Dietary carbohydrates and the FTO gene
Gholamalizadeh 
et al. (51)
Macronutrients and the 
FTO gene expression in 
hypothalamus; a systematic 





The effect of dietary 
carbohydrates 
on the FTO gene 
expression
Dietary carbohydrates can 




Fat and carbohydrate intake 
modify the association between 
genetic variation in the FTO 
genotype and obesity
Cross-sectional The impact of 
carbohydrate intake 
on the association 
between FTO and 
BMI
The relation between FTO 
gene polymorphisms and 
obesity can be seen only 
in people who have a low 
carbohydrate intake
Qi et al. (53) FTO genetic variants, dietary 
intake, and BMI: Insights from 
177,330 individuals. 
Cross-sectional The impact of 
carbohydrate intake 
on the association 
between FTO and 
BMI
Carbohydrate intake had no 
effect on the relationship 
between FTO and BMI
Body mass index (BMI), glycemic index (GI), glycemic load (GL), fasting blood sugar (FBS), blood sugar (BS), fat mass and obesity-associated (FTO), 
















Figure 1. The effect of dietary carbohydrate on cell growth and survival through altering the FTO 
gene expression
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